世界の末梢動脈疾患（PAD）治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Peripheral Arterial Disease (PAD) Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4518
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、末梢動脈疾患（PAD）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（クロピドグレル（Plavix）、プラスグレル（Effient）、チカグレロル（Brilinta）、ボラパクサール（Zontivity）、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・末梢動脈疾患（PAD）治療薬の市場動向
・企業の競争状況、市場シェア
・末梢動脈疾患（PAD）治療薬の種類別市場規模（クロピドグレル（Plavix）、プラスグレル（Effient）、チカグレロル（Brilinta）、ボラパクサール（Zontivity）、その他）
・末梢動脈疾患（PAD）治療薬の用途別市場規模（病院、診療所、その他）
・末梢動脈疾患（PAD）治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・末梢動脈疾患（PAD）治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・末梢動脈疾患（PAD）治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・末梢動脈疾患（PAD）治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・末梢動脈疾患（PAD）治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca Plc. (UK)、Bayer HealthCare Pharmaceuticals (Germany)、Bristol-Myers Squibb Company (US)、Merck & Co., Inc. (US)、Proteon Therapeutics, Inc. (US)、Sanofi S.A. (France)、Symic Bio, Inc. (US)、TheraVasc Inc. (US)）
・結論

Market Analysis and Insights: Global Peripheral Arterial Disease (PAD) Drugs Market
The global Peripheral Arterial Disease (PAD) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peripheral Arterial Disease (PAD) Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peripheral Arterial Disease (PAD) Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peripheral Arterial Disease (PAD) Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peripheral Arterial Disease (PAD) Drugs market.

Global Peripheral Arterial Disease (PAD) Drugs Scope and Market Size
Peripheral Arterial Disease (PAD) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peripheral Arterial Disease (PAD) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Clopidogrel (Plavix)
Prasugrel (Effient)
Ticagrelor (Brilinta)
Vorapaxar (Zontivity)
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Clopidogrel (Plavix)
1.2.3 Prasugrel (Effient)
1.2.4 Ticagrelor (Brilinta)
1.2.5 Vorapaxar (Zontivity)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Peripheral Arterial Disease (PAD) Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Peripheral Arterial Disease (PAD) Drugs Market Perspective (2016-2027)
2.2 Peripheral Arterial Disease (PAD) Drugs Growth Trends by Regions
2.2.1 Peripheral Arterial Disease (PAD) Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peripheral Arterial Disease (PAD) Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Peripheral Arterial Disease (PAD) Drugs Industry Dynamic
2.3.1 Peripheral Arterial Disease (PAD) Drugs Market Trends
2.3.2 Peripheral Arterial Disease (PAD) Drugs Market Drivers
2.3.3 Peripheral Arterial Disease (PAD) Drugs Market Challenges
2.3.4 Peripheral Arterial Disease (PAD) Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Peripheral Arterial Disease (PAD) Drugs Players by Revenue
3.1.1 Global Top Peripheral Arterial Disease (PAD) Drugs Players by Revenue (2016-2021)
3.1.2 Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Peripheral Arterial Disease (PAD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peripheral Arterial Disease (PAD) Drugs Revenue
3.4 Global Peripheral Arterial Disease (PAD) Drugs Market Concentration Ratio
3.4.1 Global Peripheral Arterial Disease (PAD) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Arterial Disease (PAD) Drugs Revenue in 2020
3.5 Peripheral Arterial Disease (PAD) Drugs Key Players Head office and Area Served
3.6 Key Players Peripheral Arterial Disease (PAD) Drugs Product Solution and Service
3.7 Date of Enter into Peripheral Arterial Disease (PAD) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Peripheral Arterial Disease (PAD) Drugs Breakdown Data by Type
4.1 Global Peripheral Arterial Disease (PAD) Drugs Historic Market Size by Type (2016-2021)
4.2 Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Type (2022-2027)

5 Peripheral Arterial Disease (PAD) Drugs Breakdown Data by Application
5.1 Global Peripheral Arterial Disease (PAD) Drugs Historic Market Size by Application (2016-2021)
5.2 Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027)
6.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type
6.2.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021)
6.2.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027)
6.2.3 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027)
6.3 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application
6.3.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021)
6.3.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027)
6.3.3 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027)
6.4 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country
6.4.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021)
6.4.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027)
7.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type
7.2.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021)
7.2.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027)
7.2.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027)
7.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application
7.3.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021)
7.3.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027)
7.3.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027)
7.4 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country
7.4.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021)
7.4.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027)
8.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type
8.2.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application
8.3.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region
8.4.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027)
9.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type
9.2.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027)
9.3 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application
9.3.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027)
9.4 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country
9.4.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027)
10.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type
10.2.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application
10.3.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country
10.4.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca Plc. (UK)
11.1.1 AstraZeneca Plc. (UK) Company Details
11.1.2 AstraZeneca Plc. (UK) Business Overview
11.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Introduction
11.1.4 AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.1.5 AstraZeneca Plc. (UK) Recent Development
11.2 Bayer HealthCare Pharmaceuticals (Germany)
11.2.1 Bayer HealthCare Pharmaceuticals (Germany) Company Details
11.2.2 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
11.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Introduction
11.2.4 Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.2.5 Bayer HealthCare Pharmaceuticals (Germany) Recent Development
11.3 Bristol-Myers Squibb Company (US)
11.3.1 Bristol-Myers Squibb Company (US) Company Details
11.3.2 Bristol-Myers Squibb Company (US) Business Overview
11.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Introduction
11.3.4 Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.3.5 Bristol-Myers Squibb Company (US) Recent Development
11.4 Merck & Co., Inc. (US)
11.4.1 Merck & Co., Inc. (US) Company Details
11.4.2 Merck & Co., Inc. (US) Business Overview
11.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Introduction
11.4.4 Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.4.5 Merck & Co., Inc. (US) Recent Development
11.5 Proteon Therapeutics, Inc. (US)
11.5.1 Proteon Therapeutics, Inc. (US) Company Details
11.5.2 Proteon Therapeutics, Inc. (US) Business Overview
11.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Introduction
11.5.4 Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.5.5 Proteon Therapeutics, Inc. (US) Recent Development
11.6 Sanofi S.A. (France)
11.6.1 Sanofi S.A. (France) Company Details
11.6.2 Sanofi S.A. (France) Business Overview
11.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Introduction
11.6.4 Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.6.5 Sanofi S.A. (France) Recent Development
11.7 Symic Bio, Inc. (US)
11.7.1 Symic Bio, Inc. (US) Company Details
11.7.2 Symic Bio, Inc. (US) Business Overview
11.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Introduction
11.7.4 Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.7.5 Symic Bio, Inc. (US) Recent Development
11.8 TheraVasc Inc. (US)
11.8.1 TheraVasc Inc. (US) Company Details
11.8.2 TheraVasc Inc. (US) Business Overview
11.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Drugs Introduction
11.8.4 TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
11.8.5 TheraVasc Inc. (US) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Clopidogrel (Plavix)
Table 3. Key Players of Prasugrel (Effient)
Table 4. Key Players of Ticagrelor (Brilinta)
Table 5. Key Players of Vorapaxar (Zontivity)
Table 6. Key Players of Others
Table 7. Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions (2016-2021)
Table 11. Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions (2022-2027)
Table 13. Peripheral Arterial Disease (PAD) Drugs Market Trends
Table 14. Peripheral Arterial Disease (PAD) Drugs Market Drivers
Table 15. Peripheral Arterial Disease (PAD) Drugs Market Challenges
Table 16. Peripheral Arterial Disease (PAD) Drugs Market Restraints
Table 17. Global Peripheral Arterial Disease (PAD) Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Players (2016-2021)
Table 19. Global Top Peripheral Arterial Disease (PAD) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Arterial Disease (PAD) Drugs as of 2020)
Table 20. Ranking of Global Top Peripheral Arterial Disease (PAD) Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Peripheral Arterial Disease (PAD) Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Peripheral Arterial Disease (PAD) Drugs Product Solution and Service
Table 24. Date of Enter into Peripheral Arterial Disease (PAD) Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Peripheral Arterial Disease (PAD) Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. AstraZeneca Plc. (UK) Company Details
Table 65. AstraZeneca Plc. (UK) Business Overview
Table 66. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Drugs Product
Table 67. AstraZeneca Plc. (UK) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 68. AstraZeneca Plc. (UK) Recent Development
Table 69. Bayer HealthCare Pharmaceuticals (Germany) Company Details
Table 70. Bayer HealthCare Pharmaceuticals (Germany) Business Overview
Table 71. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Product
Table 72. Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 73. Bayer HealthCare Pharmaceuticals (Germany) Recent Development
Table 74. Bristol-Myers Squibb Company (US) Company Details
Table 75. Bristol-Myers Squibb Company (US) Business Overview
Table 76. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Product
Table 77. Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 78. Bristol-Myers Squibb Company (US) Recent Development
Table 79. Merck & Co., Inc. (US) Company Details
Table 80. Merck & Co., Inc. (US) Business Overview
Table 81. Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Drugs Product
Table 82. Merck & Co., Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 83. Merck & Co., Inc. (US) Recent Development
Table 84. Proteon Therapeutics, Inc. (US) Company Details
Table 85. Proteon Therapeutics, Inc. (US) Business Overview
Table 86. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Product
Table 87. Proteon Therapeutics, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 88. Proteon Therapeutics, Inc. (US) Recent Development
Table 89. Sanofi S.A. (France) Company Details
Table 90. Sanofi S.A. (France) Business Overview
Table 91. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Drugs Product
Table 92. Sanofi S.A. (France) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 93. Sanofi S.A. (France) Recent Development
Table 94. Symic Bio, Inc. (US) Company Details
Table 95. Symic Bio, Inc. (US) Business Overview
Table 96. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Drugs Product
Table 97. Symic Bio, Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 98. Symic Bio, Inc. (US) Recent Development
Table 99. TheraVasc Inc. (US) Company Details
Table 100. TheraVasc Inc. (US) Business Overview
Table 101. TheraVasc Inc. (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million)
Table 102. TheraVasc Inc. (US) Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Type: 2020 VS 2027
Figure 2. Clopidogrel (Plavix) Features
Figure 3. Prasugrel (Effient) Features
Figure 4. Ticagrelor (Brilinta) Features
Figure 5. Vorapaxar (Zontivity) Features
Figure 6. Others Features
Figure 7. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Peripheral Arterial Disease (PAD) Drugs Report Years Considered
Figure 12. Global Peripheral Arterial Disease (PAD) Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Peripheral Arterial Disease (PAD) Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions: 2020 VS 2027
Figure 15. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions (2022-2027)
Figure 16. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Players in 2020
Figure 17. Global Top Peripheral Arterial Disease (PAD) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Arterial Disease (PAD) Drugs as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Peripheral Arterial Disease (PAD) Drugs Revenue in 2020
Figure 19. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2022-2027)
Figure 21. North America Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027)
Figure 23. North America Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027)
Figure 24. North America Peripheral Arterial Disease (PAD) Drugs Market Share by Country (2016-2027)
Figure 25. United States Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027)
Figure 29. Europe Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027)
Figure 30. Europe Peripheral Arterial Disease (PAD) Drugs Market Share by Country (2016-2027)
Figure 31. Germany Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Share by Region (2016-2027)
Figure 41. China Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027)
Figure 49. Latin America Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027)
Figure 50. Latin America Peripheral Arterial Disease (PAD) Drugs Market Share by Country (2016-2027)
Figure 51. Mexico Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Share by Country (2016-2027)
Figure 57. Turkey Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AstraZeneca Plc. (UK) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 61. Bayer HealthCare Pharmaceuticals (Germany) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 62. Bristol-Myers Squibb Company (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 63. Merck & Co., Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 64. Proteon Therapeutics, Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 65. Sanofi S.A. (France) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 66. Symic Bio, Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 67. TheraVasc Inc. (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Global Peripheral Arterial Disease (PAD) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4519 2021年4月 99Pages
QYResearch社発行の本調査資料では、末梢動脈疾患（PAD）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗血小板薬、二重抗血小板療法薬、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の口内乾燥症（口渇症）治療薬市場規模・現状・予測（2021年-2027年）

Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z6093 2021年4月 99Pages
QYResearch社発行の本調査資料では、口内乾燥症（口渇症）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（人工唾液、唾液刺激剤、唾液代替物、薬物、唾液ペン、その他）、用途別市場規模（小売薬局、病院薬局、オンライン薬局）、主要地域別市...

世界のフォンウィルブランド病（VWD）治療薬市場規模・現状・予測（2021年-2027年）

Global Von Willebrand Disease (VWD) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5967 2021年4月 96Pages
QYResearch社発行の本調査資料では、フォンウィルブランド病（VWD）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（デスモプレシン、血栓安定化薬、線維素溶解阻害剤、補充療法、その他）、用途別市場規模（病院薬局、小売薬局、オンライン...

世界の急性反復発作（ARS）治療薬市場規模・現状・予測（2021年-2027年）

Global Acute Repetitive Seizures Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z0077 2021年4月 99Pages
QYResearch社発行の本調査資料では、急性反復発作（ARS）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、胃腸、その他）、用途別市場規模（病院、研究所、薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の急性反復発作（ARS）治療薬市場規模・現状・予測（2021年-2027年）

世界の加齢黄斑変性症（ARMD）治療薬市場規模・現状・予測（2021年-2027年）

Global Age-relatedMacularDegeneration (ARMD) Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z0160 2021年4月 90Pages
QYResearch社発行の本調査資料では、加齢黄斑変性症（ARMD）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗VEGF薬、感光性薬、その他）、用途別市場規模（滲出性ARMD、萎縮性ARMD）、主要地域別市場規模（北米、アメリカ、...

世界の加齢黄斑変性症（ARMD）治療薬市場規模・現状・予測（2021年-2027年）

世界の黄斑変性症（AMD）・糖尿病性網膜症（DR）治療薬市場規模・現状・予測（2021年-2027年）

Global Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z3523 2021年4月 90Pages
QYResearch社発行の本調査資料では、黄斑変性症（AMD）・糖尿病性網膜症（DR）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（黄斑変性症治療薬、糖尿病性網膜症治療薬）、用途別市場規模（50〜60歳、60〜70歳、その他）、主要地...

世界の非アルコール性脂肪性肝炎（NASH）治療薬市場規模・現状・予測（2021年-2027年）

Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z4157 2021年4月 95Pages
QYResearch社発行の本調査資料では、非アルコール性脂肪性肝炎（NASH）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビタミンE＆ピオグリタゾン、オベチコール酸（OCA）、エラフィブラノール、セロンセルチブ＆セニクリビロク）、用...

世界の筋萎縮性側索硬化症（ALS）治療薬市場規模・現状・予測（2021年-2027年）

Global Amyotrophic Lateral Sclerosis Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z0302 2021年4月 99Pages
QYResearch社発行の本調査資料では、筋萎縮性側索硬化症（ALS）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リルゾール、エダラボン（ラジカバ）、CoQ10、ブチルフタリド、その他）、用途別市場規模（病院薬局、小売薬局、オンライ...

世界の末梢動脈疾患（PAD）治療薬市場規模・現状・予測（2021年-2027年） Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the…
世界の3D動脈スピンラベリング（3D ASL）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global 3D Arterial Spin Labeling (3D ASL) Market The global 3D Arterial Spin Labeling (3D ASL) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high …
世界のクラッベ病治療薬市場規模・現状・予測（2021年-2027年） Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to mak…
世界のクラッベ病治療薬市場規模・現状・予測（2021年-2027年） Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquired hereditary sickness, which implies that it is passed down in families. Individuals with Krabbe disease are not able to make a sufficient substance called galactosylceramidase, which is expected to mak…
世界のメニエール病治療薬市場規模・現状・予測（2021年-2027年） Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease bu…